'I was diagnosed with dementia in my 40s'
It meant leaving his job and adapting to a new way of life.
Now, aged 56, Peter is passionate about addressing the stigma around the condition often associated with elderly people.
"I might not always be able to express it in the same way, but I'm still the same person I was, inside I'm still Peter," he told BBC News NI.
Peter was 49 when he made an appointment with a neurologist and was sent for a scan.
"I was starting to struggle to meet deadlines (at work), which had never been a problem before, and during meetings, I wouldn't be able to think of a word when speaking," said Peter, who is originally from England but has lived in Northern Ireland with his wife, Jill, for several years.
"I remember the date very clearly, it was 14 January 2018 when the results came back and the doctor said: 'Peter, I have diagnosed you with having Frontotemporal dementia'.
"I was basically told that it was no longer safe for me to work because I have diminished judgment and I was losing my filter, so it was a lot to adapt to."
Frontotemporal dementia is an uncommon type of dementia that causes problems with behaviour and language.
"People think when you have dementia it's only about forgetting things but it's more complex, it can manifest in different ways.
"I don't want to be treated differently, it's imperative that people actually see the person, see beyond the condition.
"Sadly for many people, the diagnosis can take an awful long time and that puts an enormous amount of pressure on the family unit."
Dementia is a syndrome (a group of related symptoms) associated with an ongoing decline of brain functioning.
Memory loss is one of the most common symptoms, particularly the struggle to remember recent events.
Others can include changes to behaviour, mood and personality, becoming lost in familiar places, or being unable to find the right word in a conversation.
It can reach the point where people don't know when they need to eat or drink.
What are dementia and Alzheimer's and how common are they?
More than 22,000 people are living with dementia in Northern Ireland, according to the Alzheimer's Society.
The number of people living with dementia in Northern Ireland is expected to almost triple by 2051 to 60,000. The Southern Trust is expected to have the highest number of people living with the condition by 2032.
While dementia is often seen as a disease of old age, about 5% of people with dementia are classed as having young-onset dementia.
People whose symptoms started when they were under the age of 65 are often known as having young-onset dementia.
The Alzheimer's Society estimates that there are more than 70,000 people in the UK living with young-onset dementia.
In recent months, Peter has teamed up with other people in Northern Ireland living with dementia to make a film about their experience of everyday life.
The documentary called Hear Our Voice primarily focuses on people with young-onset dementia.
It offers a glimpse of what living with dementia is like, in the hope that it will create better understanding and empathy.
Peter features throughout the film and narrates it.
"Respect was granted to people who have dementia to make and take control of the film to help us get across the unique challenges we have," he said.
The film features members of Dementia NI.
The group was set up in 2015 by five people living with dementia, but 10 years on they now have 15 groups across Northern Ireland.
The groups worked alongside the Southern and South Eastern health trusts when making the Hear Our Voice project.
Dr Christopher Southwell, a consultant in Old Age Psychiatry in the Southern Trust, believes the film promotes a powerful message.
"Dementia is a condition that has a big impact on patients and their families and sometimes as healthcare professionals we acknowledge that there are things that can be done better," he said.
"When I got involved and eventually watched the film, it was important for me to be able to say to people like Peter and others behind the film that I do hear your voice and take on board what you're saying."
Members of Dementia NI recently met Health Minister Mike Nesbitt at Stormont.
They called on him to make reducing the time it takes to get a dementia diagnosis a priority.
Shortly after the film was released, in a statement, the health minister said: "I congratulate the trusts and Dementia NI for developing this powerful documentary which I have no doubt will challenge existing stereotypes and will be an informative way to educate people in how best to support individuals living with dementia."
Karen Kerr is head of engagement at Dementia NI.
She said: "The members are really passionate about the importance of getting an early diagnosis and once you get an early diagnosis it opens up a lot of opportunities so that you can continue to live well with a sense of purpose and that's also what the film is trying to highlight.
"When you hear from people like Peter, I think it demonstrates that people with dementia have a voice not just for themselves but for everyone affected with dementia."
Peter added: "When it comes to people like me with dementia, please don't write us off, we have a voice, dementia doesn't define us."
What is Alzheimer's and how common is it?
Hi-tech dementia wristbands offer 'reassurance and comfort'
'I know I'm going to have early onset dementia'
The old objects helping those with dementia remember
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hill
an hour ago
- The Hill
Senate panel rejects Trump cuts to NIH, other health agencies
The Senate Appropriations Committee rejected the Trump administration's massive proposed funding cut to the National Institutes of Health, advancing a measure that would increase the agency's budget by $400 million. The White House budget called for slashing NIH by $18 billion, a decrease of 40 percent. Instead, the committee advanced the bill on a 26-3 vote, delivering a bipartisan rebuke of the administration's efforts to defund medical research. 'This committee has had multiple hearings over the last several months and heard from patients, families and researchers about the importance of NIH funding,' said Sen. Tammy Baldwin (D-Wis.). 'This committee has, in a bipartisan manner, prioritized NIH and the research it supports to develop life-saving treatments and cures for devastating diseases.' The committee rejected the administration's plan to revamp the way NIH pays universities, medical schools, and other research centers for overhead costs, as well as a proposal to restructure the agency and consolidate all 27 NIH institutes into eight new entities. The bill includes a $100 million increase for Alzheimer's disease research, a $150 million increase for cancer research, and a $30 million increase for the Office of Research on Women's Health. 'To the scientists wondering if there will even be an NIH by the end of this administration: this committee's resounding message is yes,' said Sen. Patty Murray (D-Wash.), the committee's vice chair. 'Congress has your back — we're not going to give up the fight against cancer, Alzheimer's, or rare diseases,' Murray said. Democratic committee members also expressed frustration at the White House Office of Management and Budget's (OMB) repeated encroachments into the appropriations process and attempts to halt spending of money that was already approved by Congress. Since President Trump took office, NIH has terminated or frozen nearly 5,000 awards totaling $4 billion, while another approximately $15 billion has not yet been obligated. 'Right now, they are illegally hiding apportionments data that would let us know whether funds we passed are being spent as intended and help us strengthen the bills we are in the middle of writing on. It is absurd we have to mark up bills, while being kept in the dark,' Murray said. Murray and other members repeatedly mentioned an OMB memo from earlier this week that, through a footnote, abruptly prevented NIH from issuing grants. While the decision was reversed, Democrats said it showed the administration's disdain for congressional spending authority. 'One footnote, from an unelected bureaucrat — overruling Congress and even NIH, to block $15 billion in funding for things like cancer research,' Murray said. Outside of NIH, the bill maintains flat funding for other health agencies and programs, including the Title X family planning program and domestic HIV prevention. The bill also rejected the nearly $4 billion — or 50 percent — cut and consolidation to Centers for Disease Control and Prevention programs included in the White House budget request. But looming over the process is the possibility of another rescissions package from the administration. 'Should the administration put forward a new rescissions package, in many cases, in our bill, we have rejected proposals that the President has made to make drastic cuts. That's Congress speaking up and saying we have a different position on that, and so I expect my Republican colleagues will stand by the decisions we've made,' Baldwin told reporters ahead of the hearing. Still, the HHS budget is far from being final. The House has so far only passed two of its annual funding bills, and has not held an Appropriations Committee markup on its version of the HHS bill.
Yahoo
8 hours ago
- Yahoo
Scientists Find 2 Existing Drugs Can Reverse Alzheimer's Brain Damage in Mice
In efforts to beat Alzheimer's disease, researchers are looking at existing drugs that could tackle the condition, and a new study identifies two promising candidates that are currently used to treat cancer. Already approved by regulators in the US – meaning potential clinical trials for Alzheimer's could start sooner – the drugs are letrozole (usually used to treat breast cancer) and irinotecan (usually used to treat colon and lung cancer). Researchers from the University of California, San Francisco (UCSF) and Gladstone Institutes started by looking at how Alzheimer's altered gene expression in the brain. They then consulted a medical database called the Connectivity Map to look for drugs that reversed these gene expression changes, and cross-referenced records of patients who had taken these drugs as part of cancer treatments and their likelihood of developing Alzheimer's. Intriguingly, the drugs seemed to have reduced their risk. Related: "Alzheimer's disease comes with complex changes to the brain, which has made it tough to study and treat, but our computational tools opened up the possibility of tackling the complexity directly," says computational biologist Marina Sirota, from UCSF. "We're excited that our computational approach led us to a potential combination therapy for Alzheimer's based on existing FDA-approved medications." Having picked out letrozole and irinotecan as the best candidates, the researchers tested them in mouse models of Alzheimer's. When used in tandem, the drugs were shown to reverse some of the brain changes brought on by the disease. The harmful clumps of tau protein that build up in brains affected by Alzheimer's were reduced significantly, and the mice showed improvements in learning and memory tasks – two brain capabilities often impaired by Alzheimer's. By combining the two drugs together, the researchers were able to target different types of brain cells affected by the disease. Letorozole seemed to counter Alzheimer's in neurons, while irinotecan worked in glia. "Alzheimer's is likely the result of numerous alterations in many genes and proteins that, together, disrupt brain health," says neuroscientist Yadong Huang, from UCSF and Gladstone. "This makes it very challenging for drug development – which traditionally produces one drug for a single gene or protein that drives disease." It's a promising start, but there's more work to be done: obviously the drugs have only been directly tested in mice so far, and these medications also come with side effects attached. They need to be reconsidered if the drugs are going to be repurposed for a different disease than what they were originally approved for. One of the next steps should be clinical trials for people with Alzheimer's disease. According to the researchers, this approach could lead to more personalized and effective treatments, based on how gene expression has been altered in each case. It's estimated that more than 55 million people have Alzheimer's today, and as the world's population ages, that's expected to more than double in the next 25 years. Finding ways to prevent the disease and even reverse symptoms would have a huge impact on global health. "If completely independent data sources, such as single-cell expression data and clinical records, guide us to the same pathways and the same drugs, and then resolve Alzheimer's in a genetic model, then maybe we're on to something," says Sirota. "We're hopeful this can be swiftly translated into a real solution for millions of patients with Alzheimer's." The research has been published in Cell. Related News Psilocybin Extends Life of Human Cells by 50% in Wild New Study Celebrity Undergoes Controversial Procedure to Clean Blood of Microplastics COVID Can Cause Alzheimer's-Like Plaques in Eyes And Brain Solve the daily Crossword
Yahoo
9 hours ago
- Yahoo
Sleepiness Could Be Triggered by a Power Overload in Our Brain
Denied of sleep, we find it but impossible to keep our eyes open and our thoughts focused. A new study based on fruit flies may have pin-pointed the origins of this biological lullaby, and with it a deeper understanding of our need for rest on a cellular level. Researchers from the University of Oxford in the UK have identified our cell's mitochondria as responsible for signaling when the body has to get some shut-eye as soon as possible. These tiny power generators cause a kind of metabolic overload in sleep-regulating neurons, the researchers suggest, which in simple terms indicates when our brain is running on empty. Through sleep, this overload can be reset, ensuring the brain remains in a healthy state. Related: "We set out to understand what sleep is for, and why we feel the need to sleep at all," says physiologist Gero Miesenböck. "Despite decades of research, no one had identified a clear physical trigger." "Our findings show that the answer may lie in the very process that fuels our bodies: aerobic metabolism." The team studied neurons responsible for regulating sleep in fruit flies, which have enough biological similarities to humans to make them useful for research. Through a comparison of well-rested and sleep-deprived fruit flies, the researchers identified differences in gene activity and electrical signaling. Overloaded mitochondria in sleep-deprived brains were found to shed electrons, increasing the generation of harmful waste products. The sleep-regulating neurons respond to these molecules by going into overdrive, making sleep a top biological priority. "You don't want your mitochondria to leak too many electrons," says neuroscientist Raffaele Sarnataro. "When they do, they generate reactive molecules that damage cells." Genetically engineering flies with a higher production of electrons in their sleep-regulating cells resulted in fruit flies that also slept more. Similarly, flies with a reduced level of electron generation slept less. There are, of course, other pressures on sleep, from how many coffees you have per day to the alignment of your circadian rhythm – the internal schedule that tells your body when it's time for bed. But now we have an actual cellular mechanism controlling sleep, and showing why we can't do without it. Anything new we learn about sleep can inform the treatment of sleep disorders and even neurological conditions such as Alzheimer's. These diseases are closely linked to sleep and the way it protects the brain, and connections to mitochondria could be something for future studies to investigate. The study also joins some of the dots between metabolism, sleep, and lifespan. Smaller animals tend to sleep more and live shorter lives, and the activity of mitochondria – and the waste that needs clearing up – could be part of the reason why. "This research answers one of biology's big mysteries," says Sarnataro. "Why do we need sleep? The answer appears to be written into the very way our cells convert oxygen into energy." The research has been published in Nature. Related News Study Reveals Key Way to Slow Chronic Illness in Old Age Liver Cancer Predicted to Double by 2050, But There Is Hope One Weekend Habit May Cut Risk of Heart-Related Death by 33%, Study Finds Solve the daily Crossword